Alterity Therapeutics Limited (ATHE) Return on Investment ROI from the fourth quarter of 2025 to fourth quarter of 2024 and for the year 2025, average high and low, overall ranking from Jun 30 2025 to Jun 30 2024 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Alterity Therapeutics Limited  (NASDAQ: ATHE)


Alterity Therapeutics Limited's ROI from its fourth quarter of 2025 to the fourth quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Alterity Therapeutics Limited's ROI in the fourth quarter of 2025?
Alterity Therapeutics Limited recorded a cumulative net loss of $-12 million during 12 months ending in the fourth quarter of 2025, resulting in a negative return on investment (ROI) of -38.49%.

Within the Healthcare sector 355 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2025 from 0 to 4178.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Jun 30 2024)
IV. Quarter
Y / Y Investment Change TTM 202.91 % 125.45 % 65.38 % 17.72 % -39.44 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 28 28 28 42 9
Return On Investment (TTM) -38.49 % -71.11 % -86.05 % -108.78 % -183.52 %
ATHE's Overall Ranking # 4178 # 0 # # #
Seq. Investment Change TTM 17.37 % 21.02 % 26.41 % 68.72 % -12.65 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -12 -19 -19 -19 -19

ATHE Company Profile >> Back to ATHE Roi Comparisons >> See Annual ATHE Return On Investment



Return On Investment ATHE's Ranking
Within: No.
Industry # 132
Sector # 356
Overall # 4178

Return On Investment Statistics
High Average Low
-28.59 %
-72.69 %
-138.08 %
  (Jun 30 2024)







Financial Statements
Alterity Therapeutics Limited's IV. Quarter Investments $ 28 Millions ATHE's Balance sheet
Alterity Therapeutics Limited's IV. Quarter Income $ -12 Millions Quarterly ATHE's Income Statement
ATHE's Income by Division See ATHE's Income by Division


ATHE Annual Return On Investment (Jun 30 2025)
2025		 (Jun 30 2024)
2024		 (Jun 30 2023)
2023		 (Jun 30 2022)
2022		 (Jun 30 2021)
2021
Total Investments in Millions 28 9 15 25 23
Y / Y Investment Growth 201.79 % -39.54 % -37.56 % 7.28 % 361.38 %
Net Income in Millions -8 -13 -9 -9 -11
Y / Y Net Income Growth - - - - -
Annual Return On Investment -28.15 % -135.32 % -60.65 % -37.99 % -50 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ATHE's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ATHE's Competitors
Subscribers only: Roi for Alterity Therapeutics Limited's Suppliers
Subscribers only: Return On Investment for ATHE's Customers

Other Ratios
ATHE's Roa ATHE's Inventory Turnover Ratio ATHE's Growth Rates ATHE's Dividend Statistics
ATHE's Profitability Ratios ATHE's Asset Turnover Ratio ATHE's Dividend Growth
ATHE's Roe ATHE's Valuation Ratios ATHE's Financial Strength Ratios ATHE's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2025, within Healthcare Sector ROI

Date modified: 2026-09-10T01:49:14+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.